Alzamend Neuro Announces Topline Data For Phase 1 Trial Of AL001 For Dementia Related to Alzheimer’s Will Be Delivered Mid-To-Late Dec. 2021; IND Submission For Combined AL002 Phase 1/2 Clinical Trial Expected In Second Quarter Of 2022

by | Nov 30, 2021 | Extra Jobs | 0 comments

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.